Nicotine Dependence clinical trials
34 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Varenicline and Accelerated Transcranial Magnetic Stimulation (TMS) for Quitting Nicotine Use (Pilot Study)
- Smart Olfaction App to Reduce Relapse
- Behavioral Intervention for Youth to Promote Vaping Cessation
- Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.
- A Trial of Varenicline for E-cigarette Cessation
- Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)
- A Study Of Vagal Nerve Stimulation In Conjunction With NRT For Smoking Cessation
- E-cigarette Cessation in Adults Who Co-use Cannabis
- Social Media Support Groups for Adolescent Vaping Cessation
- Non-Invasive Deep Brain Neuromodulation for Smoking Cessation
- Young Adult Tobacco/Nicotine and Cannabis Co-use
- A Digital Intervention (ACT on Vaping App) for Vaping Cessation in Young Adult E-Cigarette Users
- Abuse Liability and Appeal of Oral Nicotine Products
- Brain/Craving Response to Smoking Cues After Oral Nicotine Pouch Use
- Orexin s Role in the Neurobiology of Substance Use Disorder
- Effects of Cannabidiol on Stress and Nicotine Withdrawal
- Neurobehavioral Mechanisms Linking Childhood Adversity to Increased Risk for Smoking
- Comparative Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine
- Re-Connect Application for Smoking Cessation
- Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- The CONQUER Trial - Cessation Of Nicotine, QUitting With E-cigarette Reduction
- Effect of Product Characteristics on the Abuse Liability of Nicotine Pouches
- NeuroControl of Nicotine Dependence
- Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder
- Defining Neurobiological Links Between Substance Use and Mental Illness
- Beta-Adrenergic Modulation of Drug Cue Reactivity
- A Virtual Reality E-cigarette Prevention and Emotion Regulation Intervention for Adolescents
- AI-Enhanced App-based Intervention for Adolescent E-cigarette Cessation
- Feasibility of a Medical-Legal Partnership Model to Connect Coal Miners QuitAid
- Sex Differences in E-Cigarette Perception
- QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428
- Developing Evidence to Inform Regulatory Policy on Nicotine Content in E-Liquids
- Understanding Vape Marketing Study
- Optimizing Tobacco Use Treatment for PLWHA
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Nicotine Dependence” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.